NEW YORK (Reuters Health)—Adding prednisone to methotrexate for early rheumatoid arthritis (RA) results in a lower initiation rate of a biologic, better radiographic outcomes and no steroid-related side effects, researchers in the Netherlands say. Although biological disease-modifying anti-rheumatic drugs (bDMARDs) have led to better control of RA and improved functioning and quality of life, they…
10 Tips for Opioid Prescribing
How to manage the risks when prescribing medications for patients in chronic pain
Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances
Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies
7 Tips That Dermatologists Want Rheumatologists to Know
Recommendations on diagnosing, treating health conditions that cross over both specialties
Treatment, Management Options for Difficult-to-Control Gout
Patient education is key to medication compliance, battling gouty flares
ANCA-Associated Vasculitis in Systemic Sclerosis
A case report
Is Shared Decision Making Possible in Rheumatology?
A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions
Autoimmune Myelofibrosis: A Case Review
Diagnosis, treatment and management of AMF in Hispanic patient with lupus
Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus
Lessons Learned from a Patient with Rheumatoid Arthritis
Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues